Targeting Skp2 could induce cancer cell apoptosis and suppress tumorigenesis [22, 23], while inhibition of Skp2-mediated p27 and E-cadherin degradation leads to cell cycle blockage and migration inhibition [24, 25]. This evidence concerns the gene SKP2 and cancer.